Melanoma Journal Articles for September 2018
Experimental Cell Research
Melanoma-released exosomes directly activate the mitochondrial apoptotic pathway of CD4+ T cells through their microRNA cargo
JiZhoua1YiYanga1WenWenWangaYuanZhangbZhengRongChencChuangLiHaocJinPingZhanga
https://doi.org/10.1016/j.yexcr.2018.08.030
Available online 25 August 2018
Dove Press
E2F3 promotes cancer growth and is overexpressed through copy number variation in human melanoma
Authors Feng Z, Peng C, Li D, Zhang D, Li X, Cui F, Chen Y, He Q
Received 14 May 2018
Accepted for publication 5 July 2018
Published 30 August 2018 Volume 2018:11 Pages 5303—5313
DOI https://doi.org/10.2147/OTT.S174103
Dove Press
Apatinib mesylate tablet in the treatment of advanced malignant melanoma
Authors Yang L, Zhu H, Luo P, Chen S, Xu Y, Wang C
Received 28 May 2018
Accepted for publication 4 July 2018
Published 31 August 2018 Volume 2018:11 Pages 5333—5338
DOI https://doi.org/10.2147/OTT.S175507
Cancer Research
Induction of paracrine signaling in metastatic melanoma cells by PPAR? agonist rosiglitazone activates stromal cells and enhances tumor growth
Christine Pich, Patrick Meylan, Beatris Mastelic-Gavillet, Nhan Thanh Nguyen, Romain Loyon, Bao Khanh Trang, Hélène Moser, Catherine Moret, Christine Goepfert, Jürg Hafner, Mitchell P. Levesque, Pedro Romero, Camilla Jandus and Liliane Michalik
DOI: 10.1158/0008-5472.CAN-18-0912
Published Online First September 5, 2018
Plos
Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis
- William P. D. Hendricks ,
- Victoria Zismann ,
- Karthigayini Sivaprakasam ,
- Christophe Legendre,
- Kelsey Poorman,
- Waibhav Tembe,
- Nieves Perdigones,
- Jeffrey Kiefer,
- Winnie Liang,
- Valerie DeLuca,
- Mitchell Stark,
- Alison Ruhe,
- Roe Froman,
- [ … ],
- Jeffrey M. Trent
- [ view all ]
- Published: September 6, 2018
- https://doi.org/10.1371/journal.pgen.1007589
Comment & Response
Clarification on Uveal Melanoma Associated With Myotonic Dystrophy—Reply
Lauren A. Dalvin, MD1,2; Jose S. Pulido, MD, MS, MBA, MPH2,3; Carol L. Shields, MD1
JAMA Ophthalmol. Published online September 6, 2018. doi:10.1001/jamaophthalmol.2018.4184
PNAS
Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti–PD-L1 to eliminate melanoma in mice
Ying Wang, Lijing Su, Matthew D. Morin, Brian T. Jones, Yuto Mifune, Hexin Shi, Kuan-wen Wang, Xiaoming Zhan, Aijie Liu, Jianhui Wang, Xiaohong Li, Miao Tang, Sara Ludwig, Sara Hildebrand, Kejin Zhou, Daniel J. Siegwart, Eva Marie Y. Moresco, Hong Zhang, Dale L. Boger, and Bruce Beutler
PNAS published ahead of print August 27, 2018 https://doi.org/10.1073/pnas.1809232115
European Journal of Cancer
Volume 103, November 2018, Pages 41-51
Review
How to MEK the best of uveal melanoma: A systematic review on the efficacy and safety of MEK inhibitors in metastatic or unresectable uveal melanoma
TheresaSteeb, AnjaWessely, ThomasRuzicka, Markus V.Heppt, CarolaBerking
Show more
https://doi.org/10.1016/j.ejca.2018.08.005
FUTURE ONCOLOGY RESEARCH ARTICLE
BRAFi/MEKi in patients with metastatic melanoma: predictive factors of complete response
Simone Ribero‡, Ottavia Malavenda‡, Paolo Fava, Chiara Astrua, Elena Marra, Simona Osella-Abate, Martina Sanlorenzo, Virginia Caliendo, Maria Teresa Fierro & Pietro Quaglino
Published Online: 10 Sep 2018 https://doi.org/10.2217/fon-2018-0386
Cancer Research
Research Briefs
Combined analysis of antigen presentation and T cell recognition reveals restricted immune responses in melanoma
Yardena Samuels, Shelly Kalaora, Yochai Wolf, Tali Feferman,
Eilon Barnea, Erez Greenstein, Dan Reshef, Itay Tirosh, Alexandre Reuben,
Sushant Patkar, Ronen Levy, Juliane Quinkhardt, Tana Omokoko, Nouar Qutob,
Ofra Golani, Jianhua Zhang, Xizeng Mao, Xingzhi Song, Chantale Bernatchez,
Cara Haymaker, Marie-Andrée Forget, Caitlin Creasy, Polina Greenberg, Brett W. Carter,
Zachary A. Cooper, Steven A. Rosenberg, Michal Lotem, Ugur Sahin, Guy Shakhar,
Eytan Ruppin, Jennifer A. Wargo, Nir Friedman and Arie AdmonDOI: 10.1158/2159-8290.CD-17-1418
Published OnlineFirst September 12, 2018
The Lancet Oncology
Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial
- Prof Reinhard Dummer, MD*
- Paolo A Ascierto, MD*
- Helen J Gogas, MD
- Ana Arance, MD
- Mario Mandala, MD
- Prof Gabriella Liszkay, MD
- et al
Published:September 12, 2018DOI:https://doi.org/10.1016/S1470-2045(18)30497-2
EMBO
Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival
Gaurav Pathria, David A Scott, Yongmei Feng, Joo Sang Lee, Yu Fujita, Gao Zhang, Avinash D Sahu, Eytan Ruppin, Meenhard Herlyn, Andrei L Osterman, Ze’ev A Ronai
DOI 10.15252/embj.201899735| Published online 12.09.2018
The EMBO Journal (2018) e99735
Molecular Therapy
ARTICLE| VOLUME 1, ISSUE 3, P275-284, MARCH 01, 2000
Immunogene Therapy for Murine Melanoma Using Recombinant Adenoviral Vectors Expressing Melanoma-Associated Antigens
- Michael A. Perricone
- Kirsten A. Claussen
- Karen A. Smith
- Johanne M. Kaplan
- Susan Piraino
- Srinivas Shankara
- Bruce L. Roberts
Open ArchiveDOI:https://doi.org/10.1006/mthe.2000.0029
Cancer research
Translational Science
Targeting USP7 Identifies a Metastasis-Competent State within Bone Marrow–Resident Melanoma CTCs
Monika Vishnoi, Debasish Boral, Haowen Liu, Marc L. Sprouse, Wei Yin, Debalina Goswami-Sewell, Michael T. Tetzlaff, Michael A. Davies, Isabella C. Glitza Oliva and Dario Marchetti
DOI: 10.1158/0008-5472.CAN-18-0644 Published September 2018
American Journal of Opthalmology
SEP 14, 2018
Gene expression profiling accurately predicts uveal melanoma metastasis
Written By: Brian P Marr MD, Spencer Langevin, MD
Cancer Research
Research Article
UBE2N promotes melanoma growth via MEK/FRA1/SOX10 signaling
Anushka Dikshit, Yingai J Jin, Simone Degan, Jihwan Hwang, Matthew W Foster, Chuan-Yuan Li and Jennifer Y Zhang
DOI: 10.1158/0008-5472.CAN-18-1040
Published OnlineFirst September 17, 2018
Cancer Discovery
Research Briefs
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
Antoni Ribas, Theresa Medina, Shivaani Kummar, Asim Amin, Anusha Kalbasi, Joseph J. Drabick, Minal Barve, Gregory A. Daniels, Deborah J. Wong, Emmett V. Schmidt, Albert F. Candia, Robert L. Coffman, Abraham C.F. Leung and Robert S. Janssen
DOI: 10.1158/2159-8290.CD-18-0280
Published OnlineFirst September 17, 2018
JAMA Dermatology
Observation
September 19, 2018
Antiphospholipid Syndrome Following Pembrolizumab Treatment of Stage IIIB Unresectable Melanoma
Adrien Sanchez, MD1; Henri Montaudie, MD1,2; Pierre Bory, MD3; et alXavier Belgodere, MD3; Thierry Passeron, MD, PhD1,2; Jean Philippe Lacour, MD, PHD1; Alexandra Picard, MD1
JAMA Dermatol. Published online September 19, 2018. doi:10.1001/jamadermatol.2018.2770
F1000 Prime
A case series of anal melanoma including the results of treatment with imatinib in selected patients.
Knowles J, Lynch AC, Warrier SK, Henderson M, Heriot AG
Colorectal Dis. 2016 Sep; 18(9):877-82 https://doi.org/10.1111/codi.13209
Mendeley
ANTI-MELANOMA ACTIVITY OF PERPHENAZINE AND PROCHLORPERAZINE IN HUMAN COLO829 AND C32 CELL LINES
Published: 20 Sep 2018 | Version 1 | DOI: 10.17632/849gx453rw.1
- Micha? Otr?ba, Monika Pajor, Jared Warncke
Dove Press
All-trans retinoic acid-encapsulated, CD20 antibody-conjugated poly(lactic-co-glycolic acid) nanoparticles effectively target and eliminate melanoma-initiating cells in vitro
Authors Chen X, Zhang Z, Yang S, Chen H, Wang D, Li J
Received 2 April 2018
Accepted for publication 12 August 2018
Published 25 September 2018 Volume 2018:11 Pages 6177—6187
DOI https://doi.org/10.2147/OTT.S169957
The Journal of Immunology
Combined HDAC and BET Inhibition Enhances Melanoma Vaccine Immunogenicity and Efficacy
Alexander Badamchi-Zadeh, Kelly D. Moynihan, Rafael A. Larocca, Malika Aid, Nicholas M. Provine, M. Justin Iampietro, Ekaterina Kinnear, Pablo Penaloza-MacMaster, Peter Abbink, Eryn Blass, John S. Tregoning, Darrell J. Irvine and Dan H. Barouch
J Immunol September 24, 2018, ji1800885; DOI: https://doi.org/10.4049/jimmunol.1800885
Review of Opthalmology
Mary E. Aronow, MD, Boston
PUBLISHED 25 SEPTEMBER 2018
Imaging Advances for Choroidal Melanoma
How recent additions to ophthalmologists’ imaging toolbox are helping with diagnosis and management of these cancers.
Molecular Cancer Therapeutics
Targeting lineage-specific MITF pathway in human melanoma cell lines by A-485, the selective small molecule inhibitor of p300/CBP
Rui Wang, Yupeng He, Valerie Robinson, Ziping Yang, Paul Hessler, Loren M Lasko, Xin Lu, Anahita Bhathena, Albert Lai, Tamar Uziel and Lloyd T. Lam
DOI: 10.1158/1535-7163.MCT-18-0511
Molecular Cancer Research
miR-122-5p Expression and Secretion in Melanoma Cells is Amplified by the LPAR3 SH3 Binding Domain to Regulate Wnt1
Charnel C. Byrnes, Wei Jia, Ali A Alshamrani, Sudeepti S Kuppa and Mandi M Murph
DOI: 10.1158/1541-7786.MCR-18-0460
EMBO
ATF4?amino acid circuits: a recipe for resistance in melanoma
Mario R Fernandez, John L Cleveland
DOI 10.15252/embj.2018100600| Published online 28.09.2018
The EMBO Journal (2018) e100600
JAMA Dermatology
Original Investigation
September 2018
Sunscreen Use and Melanoma Risk Among Young Australian Adults
Caroline G. Watts, MPH, PhD1,2,3,4; Martin Drummond, MBiost1,2,4; Chris Goumas, MPH2; et alHelen Schmid, MPH5; Bruce K. Armstrong, MBBS, PhD, FAFPHM6; Joanne F. Aitken, PhD7; Mark A. Jenkins, PhD8; Graham G. Giles, PhD8,9; John L. Hopper, PhD8; Graham J. Mann, PhD2,5; Anne E. Cust, MPH, PhD1,2,4
Author Affiliations
JAMA Dermatol. 2018;154(9):1001-1009. doi:10.1001/jamadermatol.2018.1774